Biocon gets approval for Insulin Glargine
From Mexican health authority, COFEPRIS
Biocon announced that its Insulin Glargine has been approved by COFEPRIS, the Mexican health authority, through its partner PiSA Farmaceutica (PiSA).Powered by Capital Market - Live News
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Apr 09 2015 | 9:57 PM IST